pentobarbital will reduce the level or result of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not advisable; solid cytochrome P450 enzyme inducers reduce systemic publicity to roflumilast and will reduce the therapeutic effectiveness× All Dependancy Resource information is medically review… Read More